
Sign up to save your podcasts
Or
STAT biotech reporter Jonathan Wosen joins us to discuss gene therapy pioneer Jim Wilson's exit from his decades-long tenure at the University of Pennsylvania. We also discuss the latest news in the life sciences, including the surprising collapse of a gene editing company, Eli Lilly's pitch to consumers, and more.
4.5
303303 ratings
STAT biotech reporter Jonathan Wosen joins us to discuss gene therapy pioneer Jim Wilson's exit from his decades-long tenure at the University of Pennsylvania. We also discuss the latest news in the life sciences, including the surprising collapse of a gene editing company, Eli Lilly's pitch to consumers, and more.
30,975 Listeners
1,011 Listeners
1,769 Listeners
30,269 Listeners
111,073 Listeners
485 Listeners
124 Listeners
386 Listeners
60 Listeners
88 Listeners
31 Listeners
146 Listeners
11 Listeners
45 Listeners
368 Listeners